InvestorsHub Logo
Followers 28
Posts 398
Boards Moderated 0
Alias Born 12/10/2015

Re: tradeherpete post# 161445

Saturday, 08/04/2018 10:20:30 AM

Saturday, August 04, 2018 10:20:30 AM

Post# of 458867
Thanks for this tradeherpete! One correction is that in his last statement he is referring to The Alzheimer's Precision Medicine Initiative (APMI).

The Alzheimer’s Precision Medicine Initiative (APMI) is an international collaboration of leading interdisciplinary clinicians and scientists devoted towards the implementation of PM in Neurology, Psychiatry and Neuroscience.


You can download a paper giving an overview of their work and mission here: https://www.researchgate.net/publication/313540863_A_Precision_Medicine_Initiative_for_Alzheimer's_disease_the_road_ahead_to_biomarker-guided_integrative_disease_modelin

And in an interesting side note, Dr. Hampel pointed out in a tweet last week that Janet Woodcock (Director of Center for Drug Evaluation and Research(CDER)) co-authored this paper with them earlier this year: https://www.sciencedirect.com/science/article/abs/pii/S1043661817313300

Janet Woodcock speaking on biomarker qualification:


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News